A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old

NCT00146757 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis I
Hurler Syndrome
Hurler-Scheie Syndrome
Scheie Syndrome

Interventions

BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]